Literature DB >> 10328310

Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists.

J P Beck1, M A Curry, R J Chorvat, L W Fitzgerald, P J Gilligan, R Zaczek, G L Trainor.   

Abstract

A series of thiazolo[4,5-d]pyrimidine thiones and -ones was prepared and discovered to have good binding affinity to the CRH-R1 receptor, thus showing promise as a new class of potential anxiolytics and/or antidepressants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328310     DOI: 10.1016/s0960-894x(99)00159-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Synthesis and anticancer evaluation of novel 3,5-diaryl-thiazolo[4,5-d]pyrimidin-2-one derivatives.

Authors:  Lilianna Becan; Edwin Wagner
Journal:  Med Chem Res       Date:  2012-10-04       Impact factor: 1.965

2.  Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives.

Authors:  Saleh A Bahashwan; Ahmed A Fayed; Mohamed A Ramadan; Abd El-Galil E Amr; Naif O Al-Harbi
Journal:  Int J Mol Sci       Date:  2014-11-24       Impact factor: 5.923

3.  Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.

Authors:  Bhimanna Kuppast; Katerina Spyridaki; Christophina Lynch; Yueshan Hu; George Liapakis; Gareth E Davies; Hesham Fahmy
Journal:  Med Chem       Date:  2014       Impact factor: 2.745

4.  Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonists.

Authors:  Hossam R Elgiushy; Nageh A Abou-Taleb; George G Holz; Oleg G Chepurny; Ioannis Pirmettis; Sotirios Kakabakos; Vlasios Karageorgos; George Liapakis; Amgad Albohy; Khaled A M Abouzid; Sherif F Hammad
Journal:  Bioorg Chem       Date:  2021-06-10       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.